The bottom line is:
A merger almost sounded plausible in 2011 when the rumor started. Radient had $20 million shareholder equity in Jade, they forecast $12 million revenues from India, the A/S was about 50 million shares, NuVax was just getting started in the campaign to develop CIT, and Radient was confident they would get patwentas approved for onko-sure before the existign patent expired in 2014.
Since then, Radient changed the value of Jade to zero, the revenues from India were only about $100,000 in 2011 and zero afterwards, NuVax is shut down and Radient says CIT is worthless, the A/S is 5 billion, and there is no chance of getting the one remaining patent application approved before the last patent expires.
So I don't see the point of continuing the discussion of a merger or takeover. The odds seem so prohibitively AGAINST any entity wanting to merge with, acquire, or take over this company. The PPS of 0.0001 reflects these odds.
I guess that in theory, ANY pinksheet shell could be taken over or acquired. Buying this stock in hopes of a merger or takeover requires a much higher risk tolerance than mine. So I wish the best of luck to those of you who are bigger gamblers than me -- I salute you!
